Glial pathology is modified by age in mood disorders - A systematic meta-analysis of serum S100B in vivo studies

Journal of Affective Disorders

Volumn 134, Issue 1-3, 2011, Pages 32-38

  Schroeter, Matthias L ^a,b,c   Steiner, Johann ^d   Mueller, Karsten ^a  

^a MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^b Queen Elisabeth Hospital   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Astrocytes; Bipolar disorder; Glia; Major depressive disorder; Mood disorder; S100B

Indexed keywords

PROTEIN S100B;

BIPOLAR MANIA; DISEASE DURATION; GLIA; GROUPS BY AGE; HUMAN; IN VIVO STUDY; MAJOR DEPRESSION; MEDLINE; MOOD DISORDER; NERVE CELL PLASTICITY; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REVIEW; SYSTEMATIC REVIEW;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; MOOD DISORDERS; NERVE GROWTH FACTORS; NEUROGLIA; S100 PROTEINS;

EID: 79952795819     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2010.11.008     Document Type: Review

References (35)

1. A.C. Andreazza, C. Cassini, A.R. Rosa, M.C. Leite, L.M.V. de Almeida, P. Nardin, A.B.N. Cunha, K.M. Cereser, A. Santin, C. Gottfried, M. Salvador, F. Kapczinski, and C.A. Goncalves Serum S100B and antioxidant enzymes in bipolar patients J. Psychiatr. Res. 41 2007 523 529 (Pubitemid 46227446)
2. V. Arolt, M. Peters, A. Erfurth, M. Wiesmann, U. Missler, S. Rudolf, H. Kirchner, and M. Rothermundt S100B and response to treatment in major depression: a pilot study Eur. Neuropsychopharmacol. 13 2003 235 239 (Pubitemid 36904049)
3. M. Banasr, and R.S. Duman Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors Biol. Psychiatry 64 2008 863 870
4. J. Cohen Statistical Power Analysis for the Behavioral Sciences 2nd ed. 1988 Lawrence Earlbaum Associates Hillsdale, NJ
5. H. Cooper, and L.V. Hedges The Handbook of Research Synthesis 1994 Russell Sage Foundation Publications New York
6. B. Czéh, M. Simon, B. Schmelting, C. Hiemke, and E. Fuchs Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment Neuropsychopharmacology 31 2006 1616 1626 (Pubitemid 44106693)
7. B. Dean, L. Gray, and E. Scarr Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia Aust N Z J Psychiatry 40 2006 217 224 (Pubitemid 43379420)
8. D.E. Dietrich, U. Hauser, M. Peters, Y. Zhang, M. Wiesmann, M. Hasselmann, S. Rudolf, O. Jüngling, H. Kirchner, T.F. Münte, V. Arolt, H.M. Emrich, S. Johannes, and M. Rothermundt Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression Neurosci. Lett. 354 2004 69 73 (Pubitemid 38041102)
9. R. Donato S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles Int. J. Biochem. Cell Biol. 33 2001 637 668 (Pubitemid 32520962)
10. G. Hetzel, O. Moeller, S. Evers, A. Erfurth, G. Ponath, V. Arolt, and M. Rothermundt The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment Psychopharmacology 178 2005 161 166 (Pubitemid 40379210)
11. N. Johnston-Wilson, C.D. Sims, J.P. Hofmann, L. Anderson, A.D. Shore, E.F. Torrey, and R. Yolken Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder and major depressive disorder Mol. Psychiatry 5 2000 142 149 (Pubitemid 30229428)
12. G.M. Jow, T.T. Yang, and C.L. Chen Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia J. Affect. Disord. 90 2006 21 27
13. A.A. Khundakar, and A.J. Thomas Morphometric changes in early- and late-life major depressive disorder: evidence from postmortem studies Int. Psychogeriatr. 21 2009 844 854
14. Klempan T.A., Sequeira A., Canetti L., Lalovic A., Ernst C., Ffrench-Mullen J., and Turecki G. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression Mol. Psychiatry 14 2009 175 189
15. R. Machado-Vieira, D.R. Lara, L.V. Portela, C.A. Goncalves, J.C. Soares, F. Kapczinski, and D.O. Souza Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study Eur. Neuropsychopharmacol. 12 2002 269 272 (Pubitemid 34462220)
16. H. Manev, T. Uz, and R. Manev Glia as a putative target for antidepressant treatments J. Affect. Disord. 75 2003 59 64 (Pubitemid 36645020)
17. J.J. Miguel-Hidalgo, C. Baucom, G. Dilley, J. Overholser, H.Y. Meltzer, C.A. Stockmeier, and G. Rajkowska Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder Biol. Psychiatry 48 2000 861 873
18. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, and D.F. Stroup Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement Lancet 354 1999 1896 1900
19. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman the PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann. Intern. Med. 151 2009 264 269
20. G. Rajkowska Dysfunction of neural circuits involved in the pathophysiology of mood disorders: postmortem studies in mood disorders indicate altered numbers of neurons and glial cells Biol. Psychiatry 48 2000 766 777
21. G. Rajkowska, and J.J. Miguel-Hidalgo Gliogenesis and glial pathology in depression CNS Neurol. Disord. Drug Targets 6 2007 219 233 (Pubitemid 46916253)
22. M. Rothermundt, V. Arolt, M. Wiesmann, U. Missler, M. Peters, S. Rudolf, and H. Kirchner S100B is increased in melancholic but not in non-melancholic major depression J. Affect. Disord. 66 2001 89 93 (Pubitemid 32787051)
23. M.L. Schroeter, and J. Steiner Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders Mol. Psychiatry 14 2009 235 237
24. M.L. Schroeter, H. Abdul-Khaliq, A. Diefenbacher, and I.E. Blasig S100B is increased in mood disorders and may be reduced by antidepressive treatment NeuroReport 13 2002 1675 1678
25. M.L. Schroeter, H. Abdul-Khaliq, M. Krebs, A. Diefenbacher, and I.E. Blasig Serum markers support disease-specific glial pathology in major depression J. Affect. Disord. 111 2008 271 280
26. M.L. Schroeter, H. Abdul-Khaliq, M. Krebs, A. Diefenbacher, and I.E. Blasig Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia - original research and meta-analysis Psychiatry Res. 167 2009 66 72
27. Schroeter M.L., Abdul-Khaliq H., Sacher J., Steiner J., Blasig I.E., and Müller K. Mood disorders are glial disorders - evidence from in vivo studies Cardiovasc. Psych. Neurol. 2010 10.1155/2010/780645 ID780645
28. X. Si, J.J. Miguel-Hidalgo, G. O'Dwyer, C.A. Stockmeier, and G. Rajkowska Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression Neuropsychopharmacology 29 2004 2088 2096 (Pubitemid 39486561)
29. J. Steiner, M.L. Schroeter, K. Schiltz, H.G. Bernstein, J.J. Müller, C. Richter-Landsberg, W.E. Müller, M. Walter, T. Gos, B. Bogerts, and G. Keilhoff Haloperidol and clozapine decrease S100B release from glial cells Neuroscience 167 2010 1025 1031
30. J. Steiner, M. Walter, P. Guest, A.M. Myint, K. Schiltz, B. Panteli, M. Brauner, H.G. Bernstein, T. Gos, M. Herberth, M.L. Schroeter, M.J. Schwarz, S. Westphal, S. Bahn, and B. Bogerts Elevated S100B levels in schizophrenia are associated with insulin resistance Mol. Psychiatry 15 2010 3 4
31. N.A. Uranova, V.M. Vostrikov, D.D. Orlovskaya, and V.I. Rachmanova Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium Schizophr. Res. 67 2004 269 275 (Pubitemid 38251458)
32. V.M. Vostrikov, N.A. Uranova, and D.D. Orlovskaya Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders Schizophr. Res. 94 2007 273 280 (Pubitemid 47031593)
33. K. Yang, G.R. Xie, Y.Q. Hu, F.Q. Mao, and L.Y. Su The effects of gender and number of depressive episodes on serum S100B levels in patients with major depression J. Neural Transm. 115 2008 1687 1694
34. K. Yang, G.R. Xie, Y.Q. Hu, F.Q. Mao, and L.Y. Su Association study of astrocyte-derived protein S100B gene polymorphisms with major depressive disorder in Chinese people Can. J. Psychiatry 54 2009 312 319
35. Y. Zhang, M. Rothermundt, M. Peters, M. Wiesmann, L. Hoy, V. Arolt, H.M. Emrich, and D.E. Dietrich S100B serum levels and word memory processing in remitted major depression as reflected by brain potentials Neuropsychobiology 59 2009 172 177